Cargando…
Mitochondrial DNA Variants in Patients with Liver Injury Due to Anti-Tuberculosis Drugs
Background: Hepatotoxicity is the most severe adverse effect of anti-tuberculosis therapy. Isoniazid’s metabolite hydrazine is a mitochondrial complex II inhibitor. We hypothesized that mitochondrial DNA variants are risk factors for drug-induced liver injury (DILI) due to isoniazid, rifampicin or p...
Autores principales: | Lee, Li-Na, Huang, Chun-Ta, Hsu, Chia-Lin, Chang, Hsiu-Ching, Jan, I-Shiow, Liu, Jia-Luen, Sheu, Jin-Chuan, Wang, Jann-Tay, Liu, Wei-Lun, Wu, Huei-Shu, Chang, Ching-Nien, Wang, Jann-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723168/ https://www.ncbi.nlm.nih.gov/pubmed/31412578 http://dx.doi.org/10.3390/jcm8081207 |
Ejemplares similares
-
Accelerated progression of pulmonary tuberculosis in a COVID-19 patient after corticosteroid treatment
por: Liu, Wang-Da, et al.
Publicado: (2022) -
Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan
por: Lee, Meng-Rui, et al.
Publicado: (2017) -
Predictors and Prevalence of Latent Tuberculosis Infection in Patients Receiving Long-Term Hemodialysis and Peritoneal Dialysis
por: Shu, Chin-Chung, et al.
Publicado: (2012) -
Diagnosis of Tuberculosis by an Enzyme-Linked Immunospot Assay for Interferon-γ
por: Wang, Jann-Yuan, et al.
Publicado: (2007) -
Nine- to Twelve-Month Anti-Tuberculosis Treatment Is Associated with a Lower Recurrence Rate than 6–9-Month Treatment in Human Immunodeficiency Virus-Infected Patients: A Retrospective Population-Based Cohort Study in Taiwan
por: Wang, Jann-Yuan, et al.
Publicado: (2015)